NHS Highland is one of the fourteen regions of NHS Scotland. Geographically, it is the largest Health Board, covering an area of 32,500 km² from Kintyre in the south-west to Caithness in the north-east, serving a population of 320,000 people. In 2016–17 it had an operating budget of £780 million.

During the past decade, NHS Highland conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NHS Highland" #1 sponsor was "Jazz Pharmaceuticals" with 1 trials, followed by "NHS Greater Glasgow and Clyde" with 1 trials sponsored, "Nutricia UK Ltd" with 1 trials sponsored, "Queen Mary University of London" with 1 trials sponsored and "The University of Queensland" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NHS Highland" #1 collaborator was "University of Glasgow" with 2 trials as a collaborator, "Achieve Life Sciences" with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Insmed Incorporated" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "NHS Highland" are "Covid19" (1 trials), "Decreased Fetal Movements Affecting Care of Mother" (1 trials), "Diabetic Retinopathy" (1 trials), "Hyperphosphatemia" (1 trials) and "Kidney Failure, Chronic" (1 trials). Many other conditions were trialed in "NHS Highland" in a lesser frequency.

Most popular intervention types in "NHS Highland" are "Drug" (5 trials), "Dietary Supplement" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "A package of interventions" (1 trials), "Apatorsen (OGX-427)" (1 trials), "Brensocatib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "NHS Highland" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NHS Highland". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in NHS Highland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NHS Highland, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".